Skip to Content
The Big Picture San Diego Blog


Calbiotech

June 5, 2017

San Diego knows how to build companies that the rest of the world values. Case in point: Last month, El-Cajon based Calbiotech, a diagnostics company, was acquired by ERBA Mannheim, a medical device manufacturer based in Mannheim, Germany.

In 2016, Calbiotech was part of MetroConnect, World Trade Center San Diego’s flagship export assistance program. As part of the 2016 cohort, Calbiotech received financial and programmatic resources to support their plans to expand internationally.

Calbiotech has a global footprint of more than 200 products, which are distributed to 60 countries worldwide. With the expansion announcement, Calbiotech will maintain its footprint in San Diego because of the access to key reference labs and other biotech customers throughout the region. It will also serve as ERBA’s hub and gateway to the Latin American market.

The company was referred to the MetroConnect program by Jo Marie Diamond, head of the San Diego East County Economic Development Council. “I’ve been working with Calbiotech for years,” said Diamond, “They are representative of everything positive about the San Diego economy – a focus on innovative products, a strong sense of commitment to the community, and an incredibly grounded and highly diverse team.

We’re excited to hear of Calbiotech’s next step and were very impressed with the company during their time in MetroConnect”, said Lauren Lindner, director of World Trade Center San Diego who oversees the MetroConnect Program. “Their team was incredibly savvy in their rollout to international markets, and we’re not surprised to see that a leader like ERBA took notice.”

San Diego, and specifically East County, have been an integral part of the Calbiotech success story,” said David Barka, Vice President. “San Diego is home to companies that are leading the world in innovation in science and medicine. Being in San Diego gave us access to an amazing talent pool that really helped our company grow.”

The acquisition will help Calbiotech increase access to markets across Europe and Asia add to EBRA’s extensive and far-ranging product portfolio.

M&A is an important growth strategy and capital source for San Diego companies. According to a 2016 EDC study, nearly 70 percent of San Diego’s capital in 2015 came through M&A.

Calbiotech’s acquisition mirrors the region’s strengthening ties with Germany, including the announcement of Condor’s new direct flight to Frankfurt, Germany, which began operation on Monday, May 1.

Financial details of the acquisition were not disclosed.

Applications for the MetroConnect 2017 round are now open. To apply, click here.